Literature DB >> 12563048

Mevalonate kinase deficiency: enlarging the clinical and biochemical spectrum.

Viola Prietsch1, Ertan Mayatepek, Hermann Krastel, Dorothea Haas, Dorothee Zundel, Hans R Waterham, Ronald J A Wanders, K Michael Gibson, Georg F Hoffmann.   

Abstract

OBJECTIVE: Mevalonic aciduria as a result of mevalonate kinase deficiency is an inborn error of cholesterol biosynthesis characterized by dysmorphology, psychomotor retardation, progressive cerebellar ataxia, and recurrent febrile crises, usually manifesting in early infancy, accompanied by hepatosplenomegaly, lymphadenopathy, arthralgia, and skin rash. The febrile crises are similar to those observed in hyperimmunoglobulinemia D and periodic fever syndrome (HIDS). Pathogenic mutations in the mevalonate kinase gene in both disorders have demonstrated a common genetic basis. Our aim was to describe the clinical picture of adolescent patients with mevalonate kinase deficiency and to expand the clinical and biochemical spectrum of mevalonate kinase deficiency, particularly with regard to HIDS.
METHODS: We report the clinical history and biochemical findings of 3 patients with mevalonic aciduria.
RESULTS: In 2 siblings with mevalonic aciduria, a 15-year-old girl and a 14-year-old boy, the phenotype shifted with age. Ataxia has become the predominant clinical manifestation, whereas the febrile attacks occur less frequently but as yet have not disappeared. Both of them show marked elevations of immunoglobulin D (IgD). Psychomotor development is retarded but not regressive. Short stature developed in both patients. Additional findings include the development of retinal dystrophy and cataracts in both of them. The third patient is a 6-year-old boy who presented at the age of 5 years with cerebellar ataxia and retinal dystrophy. He is different from all known patients with mevalonic aciduria because of the mild neurologic involvement and because he has never developed febrile crises. In addition, levels of IgD were repeatedly normal.
CONCLUSION: The clinical and biochemical spectrum of patients with mevalonic aciduria is heterogeneous. Manifestations of the disease seem to be age dependent, as evident from this first report of adolescent patients. In patients who survive infancy, short stature, ataxia caused by cerebellar atrophy, and ocular involvement with retinal dystrophy become predominant findings. Recurrent febrile crises seem to diminish with increasing age and may not even be an obligatory finding. Elevation of IgD is most likely a secondary phenomenon that seems to be linked to recurrent febrile crises.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12563048     DOI: 10.1542/peds.111.2.258

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  20 in total

1.  Retinitis pigmentosa in mevalonate kinase deficiency.

Authors:  B Balgobind; D Wittebol-Post; J Frenkel
Journal:  J Inherit Metab Dis       Date:  2005       Impact factor: 4.982

Review 2.  Mevalonate kinase deficiency in two sisters with therapeutic response to anakinra: case report and review of the literature.

Authors:  Raquel Campanilho-Marques; Paul A Brogan
Journal:  Clin Rheumatol       Date:  2014-02-15       Impact factor: 2.980

3.  Different clinical presentation of the hyperimmunoglobulin D syndrome (HIDS) (four cases from Turkey).

Authors:  Dıdem Arslan Tas; Suzan Dınkcı; Eren Erken
Journal:  Clin Rheumatol       Date:  2012-01-14       Impact factor: 2.980

4.  A gene-based recessive diplotype exome scan discovers FGF6, a novel hepcidin-regulating iron-metabolism gene.

Authors:  Shicheng Guo; Shuai Jiang; Narendranath Epperla; Yanyun Ma; Mehdi Maadooliat; Zhan Ye; Brent Olson; Minghua Wang; Terrie Kitchner; Jeffrey Joyce; Peng An; Fudi Wang; Robert Strenn; Joseph J Mazza; Jennifer K Meece; Wenyu Wu; Li Jin; Judith A Smith; Jiucun Wang; Steven J Schrodi
Journal:  Blood       Date:  2019-02-27       Impact factor: 22.113

5.  Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome.

Authors:  Hiba M Shendi; Deirdre Walsh; J David M Edgar
Journal:  Rheumatol Int       Date:  2009-12-18       Impact factor: 2.631

Review 6.  The protean ocular involvement in monogenic autoinflammatory diseases: state of the art.

Authors:  Vittoria Bascherini; Carmela Granato; Giuseppe Lopalco; Giacomo Emmi; Lorenzo Vannozzi; Daniela Bacherini; Rossella Franceschini; Florenzo Iannone; Annabella Salerni; Francesco Molinaro; Mario Messina; Bruno Frediani; Carlo Selmi; Donato Rigante; Luca Cantarini
Journal:  Clin Rheumatol       Date:  2015-04-02       Impact factor: 2.980

7.  Nummular keratopathy in a patient with Hyper-IgD Syndrome.

Authors:  Courtney L Kraus; Susan M Culican
Journal:  Pediatr Rheumatol Online J       Date:  2009-08-05       Impact factor: 3.054

8.  Long chain fatty acid (Lcfa) abnormalities in hyper Igd syndrome (Hids) and Familial Mediterranean Fever (Fmf): new insight into heritable periodic fevers.

Authors:  Anna Simon; Joost P H Drenth; Dietrich Matern; Eric S Goetzman; Elizabeth J Hager; K Michael Gibson
Journal:  Mol Genet Metab       Date:  2013-01-15       Impact factor: 4.797

9.  Deletion of a single mevalonate kinase (Mvk) allele yields a murine model of hyper-IgD syndrome.

Authors:  E J Hager; H M Tse; J D Piganelli; M Gupta; M Baetscher; T E Tse; A S Pappu; R D Steiner; G F Hoffmann; K M Gibson
Journal:  J Inherit Metab Dis       Date:  2007-11-19       Impact factor: 4.982

10.  Diagnostic Value of Urinary Mevalonic Acid Excretion in Patients with a Clinical Suspicion of Mevalonate Kinase Deficiency (MKD).

Authors:  Jerold Jeyaratnam; Nienke M Ter Haar; Monique G M de Sain-van der Velden; Hans R Waterham; Mariëlle E van Gijn; Joost Frenkel
Journal:  JIMD Rep       Date:  2015-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.